Fig. 4. UpSet plot highlighting the intersection of multiple methods with oncogenic prediction from different datasets.

(A) Mutations were taken from the OncoKB dataset. (B) Mutations were taken from CIViC. (C) Mutations were taken from the IARC TP53 transactivation dataset. (D) Mutations were taken from in vitro cell viability by Ng et al. (42).